Novo Nordisk Rebrands as Novo Amid Turnaround Push — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Novo Nordisk said Monday it will drop the "Nordisk" and operate as "Novo," unveiling the slogan "Lasting Health Starts Now" as part of a cultural shift toward greater focus, speed, and impact
- The rebrand is tied to a broader turnaround attempt after Novo was first out of the gate in the modern GLP-1 era but has since fallen behind Eli Lilly in the obesity market
- Investors have underwhelmed by Novo's pipeline, with shares down nearly 20% over the past year amid a broader collapse from the company's 2024 peak as Europe's most valuable company
- Novo's diabetes and obesity drugs have become household names, anchoring the brand recognition the company is now trying to streamline into a shorter identity
Why it matters: A corporate rebrand is usually cosmetic, but Novo's comes after its stock lost nearly 20% over the past year and ceded obesity-market leadership to Eli Lilly, meaning management is now spending brand capital to convince shareholders the pipeline gap can be closed.
Ask SkimNews
